Warfarin Sodium
- Product NDC
- 71610-490
- 11-digit product format
- 716100490
- Labeler code
- 71610
- Product ID
- 71610-490_4d6b79ef-a2c8-4fdb-9b0b-0c050ac22b89
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Warfarin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA090935
- Marketing category
- ANDA
- Marketing start
- 2011-05-25
- Substance
- WARFARIN SODIUM
- Active strength
- 4 mg/1
- Pharmacologic classes
- Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Warfarin Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| WARFARIN SODIUM | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6153CWM0CL |
| Rxcui | 855312, 855324 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-490-30 | Warfarin Sodium | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-490 | WARFARIN SODIUM (WARFARIN) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Current NDC, Legacy NDC, 1 package rows | 20201218_a98916a5-cdb2-4251-bdea-0245c763b2f1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-490-30 | 71610049030 | 30 TABLET in 1 BOTTLE (71610-490-30) | 30 tablet | 2020-11-11 | 0000-00-00 | No | No | Current |